Protein Summary
Factor B which is part of the alternate pathway of the complement system is cleaved by factor D into 2 fragments: Ba and Bb. Bb, a serine protease, then combines with complement factor 3b to generate the C3 or C5 convertase. It has also been implicated in proliferation and differentiation of preactivated B-lymphocytes, rapid spreading of peripheral blood monocytes, stimulation of lymphocyte blastogenesis and lysis of erythrocytes. Ba inhibits the proliferation of preactivated B-lymphocytes. This gene encodes complement factor B, a component of the alternative pathway of complement activation. Factor B circulates in the blood as a single chain polypeptide. Upon activation of the alternative pathway, it is cleaved by complement factor D yielding the noncatalytic chain Ba and the catalytic subunit Bb. The active subunit Bb is a serine protease which associates with C3b to form the alternative pathway C3 convertase. Bb is involved in the proliferation of preactivated B lymphocytes, while B ...more
- ENST00000399981
- ENSP00000382862
- ENSG00000241253
- ENST00000417261
- ENSP00000414889
- ENSG00000239754
- ENST00000419411
- ENSP00000391902
- ENSG00000242335
- ENST00000419920
- ENSP00000411474
- ENST00000424727
- ENSP00000401719
- ENSG00000243570
- ENST00000425368
- ENSP00000416561
- ENSG00000243649
- ENST00000426239
- ENSP00000413351
- ENST00000427888
- ENSP00000411515
- ENST00000433503
- ENSP00000388352
- ENSG00000241534
- ENST00000436692
- ENSP00000389604
- ENST00000455591
- ENSP00000414341
- BF
- BFD
- BF
- FB
- BFD
- GBG
- CFAB
- CFBD
- PBF2
- AHUS4
- FBI12
- H2-Bf
- ARMD14
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
virus perturbation | 1 | ||
protein domain | 0.97 | ||
disease | 0.95 | ||
gene perturbation | 0.81 | ||
biological term | 0.75 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 1235.7 (req: < 5)
Gene RIFs: 109 (req: <= 3)
Antibodies: 756 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 1235.7 (req: >= 5)
Gene RIFs: 109 (req: > 3)
Antibodies: 756 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 5
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligands: 26
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0